These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 11483672)
1. Correlation between postoperative 3-[(123)I]iodo-L-alpha-methyltyrosine uptake and survival in patients with gliomas. Weber WA; Dick S; Reidl G; Dzewas B; Busch R; Feldmann HJ; Molls M; Lumenta CB; Schwaiger M; Grosu AL J Nucl Med; 2001 Aug; 42(8):1144-50. PubMed ID: 11483672 [TBL] [Abstract][Full Text] [Related]
2. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843 [TBL] [Abstract][Full Text] [Related]
3. Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas. Grosu AL; Feldmann H; Dick S; Dzewas B; Nieder C; Gumprecht H; Frank A; Schwaiger M; Molls M; Weber WA Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):842-54. PubMed ID: 12377338 [TBL] [Abstract][Full Text] [Related]
4. 3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET. Langen KJ; Ziemons K; Kiwit JC; Herzog H; Kuwert T; Bock WJ; Stöcklin G; Feinendegen LE; Müller-Gärtner HW J Nucl Med; 1997 Apr; 38(4):517-22. PubMed ID: 9098193 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy. Bader JB; Samnick S; Moringlane JR; Feiden W; Schaefer A; Kremp S; Kirsch CM Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348 [TBL] [Abstract][Full Text] [Related]
6. 123I-IMT SPECT for evaluation of the response to radiation therapy in high grade gliomas: a feasibility study. Kuczer D; Feussner A; Wurm R; Wust P; Michel R; Stockhammer F; Denecke T; Amthauer H; Felix R; Plotkin M Br J Radiol; 2007 Apr; 80(952):274-8. PubMed ID: 17121760 [TBL] [Abstract][Full Text] [Related]
8. Intra-individual comparison of p-[123I]-iodo-L-phenylalanine and L-3-[123I]-iodo-alpha-methyl-tyrosine for SPECT imaging of gliomas. Hellwig D; Romeike BF; Ketter R; Moringlane JR; Kirsch CM; Samnick S Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):24-31. PubMed ID: 17846769 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine. Kuwert T; Woesler B; Morgenroth C; Lerch H; Schäfers M; Palkovic S; Matheja P; Brandau W; Wassmann H; Schober O J Nucl Med; 1998 Jan; 39(1):23-7. PubMed ID: 9443732 [TBL] [Abstract][Full Text] [Related]
10. Comparison of O-(2-18F-fluoroethyl)-L-tyrosine PET and 3-123I-iodo-alpha-methyl-L-tyrosine SPECT in brain tumors. Pauleit D; Floeth F; Tellmann L; Hamacher K; Hautzel H; Müller HW; Coenen HH; Langen KJ J Nucl Med; 2004 Mar; 45(3):374-81. PubMed ID: 15001676 [TBL] [Abstract][Full Text] [Related]
11. Noninvasive grading of untreated gliomas: a comparative study of MR imaging and 3-(iodine 123)-L-alpha-methyltyrosine SPECT. Riemann B; Papke K; Hoess N; Kuwert T; Weckesser M; Matheja P; Wassmann H; Heindel W; Schober O Radiology; 2002 Nov; 225(2):567-74. PubMed ID: 12409596 [TBL] [Abstract][Full Text] [Related]
12. Transport mechanisms of 3-[123I]iodo-alpha-methyl-L-tyrosine in a human glioma cell line: comparison with [3H]methyl]-L-methionine. Langen KJ; Mühlensiepen H; Holschbach M; Hautzel H; Jansen P; Coenen HH J Nucl Med; 2000 Jul; 41(7):1250-5. PubMed ID: 10914918 [TBL] [Abstract][Full Text] [Related]
13. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT]. Lichy MP; Henze M; Plathow C; Bachert P; Kauczor HU; Schlemmer HP Rofo; 2004 Aug; 176(8):1114-21. PubMed ID: 15346287 [TBL] [Abstract][Full Text] [Related]
14. First experience with I-123-alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas. Grosu AL; Weber W; Feldmann HJ; Wuttke B; Bartenstein P; Gross MW; Lumenta C; Schwaiger M; Molls M Int J Radiat Oncol Biol Phys; 2000 May; 47(2):517-26. PubMed ID: 10802381 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the extension of cerebral gliomas by scintigraphy. Weckesser M; Matheja P; Rickert C; Löttgen J; Palkovic S; Riemann B; Paulus W; Wassmann H; Schober O Strahlenther Onkol; 2000 Apr; 176(4):180-5. PubMed ID: 10812391 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of amino acid transport imaging in patients with brain tumors. Weckesser M; Matheja P; Schwarzrock A; Rickert CH; Sträter R; Palkovic S; Riemann B; Kopka K; Lüdemann P; Paulus W; Wassmann H; Schober O Neurosurgery; 2002 May; 50(5):958-64; discussion 964-5. PubMed ID: 11950398 [TBL] [Abstract][Full Text] [Related]
17. [The role of L-3-I-123-iodine-alpha-methyltyrosine SPECT in cerebral gliomas]. Weckesser M; Schmidt D; Matheja P; Coenen HH; Langen KJ Nuklearmedizin; 2000 Dec; 39(8):233-40. PubMed ID: 11189900 [TBL] [Abstract][Full Text] [Related]